May 5, 2005

via U.S. Mail							via facsimile

Mr. Thomas H. Ehrlich					Alfred C. Chidester
Secretary							Baker & Hostetler LLP
Uranium Resources, Inc. 					(303) 861-7805
650 S. Edmonds, Suite 108
Lewisville, Texas 75067

Re:	Uranium Resources, Inc.
	Form 10-KSB for the year ended December 31, 2004, as amended
	Filed March 31, 2005
	File No. 0-17171

Dear Mr. Ehrlich:

      We have limited our review of the above filing to only the
areas
upon which we have issued comments.  Where indicated, we think you
should revise your documents in response to these comments.  If
you
disagree, we will consider your explanation as to why our comment
is
inapplicable or a revision is unnecessary.  Please be as detailed
as
necessary in your explanation.  In some of our comments, we may
ask
you to provide us with supplemental information so we may better
understand your disclosure.  After reviewing this information, we
may
or may not raise additional comments.

	Please understand that the purpose of our review process is
to
assist you in your compliance with the applicable disclosure
requirements and to enhance the overall disclosure in your
filings.
We look forward to working with you in these respects.  We welcome
any
questions you may have about our comments or on any other aspect
of
our review.  Feel free to call us at the telephone numbers listed
at
the end of this letter.

10-KSB for the year ended December 31, 2004

Financial Statements

Note 4 - Contract Commitments, page F-15

1. We have read your response to prior comment 11, concerning the
exposure arising from your contractual obligations to sell
uranium.
We understand that you are currently unable to produce sufficient
quantities of uranium for delivery under your contractual
obligations
in the timeframe specified.  You explain that you have not applied
fair-value accounting for that portion of your contractual
obligations
exceeding your ability to produce because you believe that your
arrangements qualify for the normal sales exception in SFAS 133.
However, as stated in paragraph 10(b) of that guidance, normal
purchases and sales are those "...that will be delivered in
quantities
expected to be used or sold by the reporting entity over a
reasonable
period in the normal course of business."

Given your disclosure on page 11, stating "the rate of production
from
Vasquez is not adequate to satisfy the annual delivery
requirements
under [your] long-term uranium sales contracts," and further
clarifying that if you are unable to secure an additional $2
million
in funding you will be "...unable to implement the plan and
produce
sufficient uranium to satisfy [your] contractual delivery
obligations," it appears your existing productive capacity,
characterizing normal operations, would preclude reliance on the
normal sales exception as justification for non-recognition.
Since
you existing productive capabilities are not sufficient to ensure
delivery of the uranium in accordance with the stated terms of
your
contractual obligations, it is not reasonable to expect that
delivery
will occur "...in the normal course of business."  Unless you have
a
formal arrangement removing the obligation to deliver, or
accommodating delivery under a timeline that coincides with your
ability to produce, fair value accounting would appear to be
necessary.

Please revise your financial statements accordingly.  Also expand
your
disclosures to convey all material terms of your contractual
arrangements, including quantities and periods in which delivery
is
required, portion of the delivery obligations exceeding your
ability
to produce, price at which you must sell the uranium, and the
forward
market prices used to apply fair value accounting at the end of
each
period.
Closing Comments

      As appropriate, please amend your filing and respond to
these
comments within 10 business days or tell us when you will provide
us
with a response.  You may wish to provide us with marked copies of
the
amendment to expedite our review.  Please furnish a cover letter
with
your amendment that keys your responses to our comments and
provides
any requested supplemental information.  Detailed cover letters
greatly facilitate our review.  Please understand that we may have
additional comments after reviewing your amendment and responses
to
our comments.

	 We urge all persons who are responsible for the accuracy and
adequacy of the disclosure in the filing reviewed by the staff to
be
certain that they have provided all information investors require
for
an informed decision.  Since the company and its management are in
possession of all facts relating to a company`s disclosure, they
are
responsible for the accuracy and adequacy of the disclosures they
have
made.

	In connection with responding to our comments, please
provide, in
writing, a statement from the company acknowledging that:

* the company is responsible for the adequacy and accuracy of the
disclosure in the filing;

* staff comments or changes to disclosure in response to staff
comments do not foreclose the Commission from taking any action
with
respect to the filing; and

* the company may not assert staff comments as a defense in any
proceeding initiated by the Commission or any person under the
federal
securities laws of the United States.

      In addition, please be advised that the Division of
Enforcement
has access to all information you provide to the staff of the
Division
of Corporation Finance in our review of your filing or in response
to
our comments on your filing.

      Please direct questions regarding accounting issues and
related
disclosures to Karl Hiller at (202) 942-1981 or, in his absence,
to
Barry Stem, Senior Assistant Chief Accountant, at (202) 942-1919.
Direct all questions regarding engineering comments to Roger Baer,
Mining Engineer, at (202) 942-2965.  Direct questions relating to
all
other disclosure issues to Jason Wynn, at (202) 824-5665 or, in
his
absence, to Tangela Richter, Branch Chief, at (202) 942-1837.
Please
send all correspondence to us at the following ZIP code:  20549-
0405.


							Sincerely,



							H. Roger Schwall
							Assistant Director


cc: 	K. Hiller
	B. Stem
	R. Baer
      J. Wynn
	T. Richter


??

??

??

??

Uranium Resources, Inc.
May 5, 2005
Page 1


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549-0405

         DIVISION OF
CORPORATION FINANCE